Adam S Faye

28PUBLICATIONS
47CO-AUTHORS
Innate immunityImmunogenetics (incl. genetic immunology)PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 15, 2026
Corticosteroid Initiation Before Antimicrobials Does Not Increase the Risk of Adverse Outcomes Among Individuals Hospitalized With an IBD Flare and Enteric Infection.

|Feb 13, 2026
The Bidirectional Relationship Between Cognitive Function and Active Inflammatory Bowel Disease.

Bharati Kochar, Adam S Faye, Elizabeth Araka

|Feb 10, 2026
Proton Pump Inhibitors Are More Cost-Effective Than Potassium Competitive Acid Blockers for Gastroesophageal Reflux Disease.

Kate L Karlin, Ella H Gilbert, Francesca Lim

|Nov 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.

Adam S Faye, David T Rubin, Corey A Siegel

|Nov 07, 2025
Clostridioides difficile Infection Is Associated With Increased Colectomy Risk in Acute Severe Ulcerative Colitis Treated With Infliximab.

Tamara F Kahan, Olivia Delau, Simon Hong

|Oct 24, 2025
Statin use for primary prevention of cardiovascular disease reduces the risk of incident IBD: A population-based cohort study.

Adam S Faye, Kristine H Allin, Gry Juul Poulsen

Pageof 5

Frequent Collaborators

5 joint publications

Jordan E Axelrad

3 joint publications

Kate L Karlin

2 joint publications

Chin Hur

2 joint publications

Bharati Kochar